An advanced regenerative blend adding KPV’s potent anti-inflammatory action to the GLOW regenerative stack.
The KLOW Blend extends the GLOW formula by adding KPV (Lys-Pro-Val), a C-terminal fragment of alpha-MSH with potent anti-inflammatory and gut-healing properties. This four-peptide combination provides comprehensive regenerative, anti-inflammatory, and gut-healing support.
Subcutaneous injection
Per prescriber guidance
“An advanced regenerative blend adding KPV’s potent anti-inflammatory action to the GLOW regenerative stack.”
GHK-Cu, BPC-157, and TB-500 provide regenerative and healing effects (see GLOW Blend). KPV adds potent anti-inflammatory action through MC1R activation, inhibiting NF-κB signaling and reducing pro-inflammatory cytokines (IL-1β, TNF-α, IL-6).
Per prescriber guidance
Daily to 3x/week
6–12 weeks
Subcutaneous injection
The addition of KPV makes this blend particularly valuable for inflammatory conditions, autoimmune issues, or gut-related pathology alongside tissue repair goals.
Add 5 mL bacteriostatic water per prescriber instructions.
Lyophilized: refrigerate. Reconstituted: refrigerate and use within 30 days.
When sourcing KLOW Blend for research purposes, the following quality benchmarks should be verified before use.
>98% (verified by HPLC)
Must be provided by supplier
<0.1 EU/mg (prevents bacterial contamination)
Manufactured in cGMP-certified facility
Independent lab verification preferred
Lyophilized: refrigerate. Reconstituted: refrigerate and use within 30 days.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.
Primarily animal studies with limited human data. Mechanism is plausible but clinical efficacy is unconfirmed.
Peptides commonly used alongside Tesamorelin / Ipamorelin / MGF for synergistic effects.
The most selective GHRP available, stimulating GH release with minimal cortisol or prolactin elevation.
The most clinically validated immunomodulatory peptide, approved in 35+ countries for hepatitis, sepsis, and immune deficiency.
Category
Status
Dose
Per prescriber guidance
Frequency
Daily to 3x/week
Cycle
6–12 weeks
Peptides
Protocols
Other Pages
Contact Us Today!
© 2026 Best Health IQ. All rights reserved.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many compounds described on this site are not approved by the FDA for human therapeutic use. Some are available only as compounded preparations or as materials sold for laboratory use, and several are on FDA's Category 2 list for significant safety risks. Nothing on this site constitutes medical advice or a recommendation to use any compound described.
